The design, synthesis, and biological evaluation of new phosphodiesterase type 4 (PDE4) inhibitors, which possessed 7-(cyclopentyloxy)-6-methoxy 1,2,3,4-tetrahydroisoquinoline ring, were described. Compound 8 [(7-cyclopentyloxy)-6-methoxy-3,4-dihydroisoquinolin-2(1H)-yl)(4-hydroxy-3-methoxy-phenyl)methanone] showed the best inhibitory activity and good selectivity against PDE4B. The docking results showed that the catechol diether moiety of compound 8 played a key role to form integral hydrogen bonds with PDE4B protein while the rest part of the molecule extended into the catalytic domain to block the access of cAMP and formed the foundation for inhibition of PDE4. Compound 8 would be great promise as a hit compound for further study based ...
Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects i...
Phosphodiesterase type 4D (PDE4D) has been indicated as a promising target for treating neurodegener...
Subtype selectivity of phosphodiesterase 4 (PDE4) has been proposed to be the most salient feature f...
The phosphodiesterase 4 (PDE4) family of enzymes is a promising drug target for a variety of conditi...
A new series of 3-(cyclopentyloxy)-4-methoxyphenyl derivatives, structurally related to our hit GEBR...
The phosphodiesterase 4 (PDE4) enzyme, which is responsible for hydrolyzing cAMP in immune cells and...
In this study, a series of pyrazole derivatives containing 4-phenyl-2-oxazole moiety were designed a...
<p>cAMP, intracellular cyclic adenosine monophosphate, is a ubiquitous second messenger that plays a...
AbstractA series of novel hybrid molecules were designed rationally by connecting an indole moiety w...
Phosphodiesterase 4 catalyzes the hydrolysis of cyclic AMP and is a target for the development of an...
PDE4 inhibitors have been identified as therapeutic targets in a variety of conditions, particularly...
A new series of 3-(cyclopentyloxy)-4-methoxyphenyl derivatives, structurally related to our hit GEBR...
The phosphodiesterase 4 (PDE4) enzyme, which is responsible for hydrolyzing cAMP in immune cells and...
A quantitative structure-activity relationship (QSAR) study was performed to develop a model on a se...
Phosphodiesterase 4B (PDE4B) is a member of the phosphodiesterase family of proteins that plays a cr...
Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects i...
Phosphodiesterase type 4D (PDE4D) has been indicated as a promising target for treating neurodegener...
Subtype selectivity of phosphodiesterase 4 (PDE4) has been proposed to be the most salient feature f...
The phosphodiesterase 4 (PDE4) family of enzymes is a promising drug target for a variety of conditi...
A new series of 3-(cyclopentyloxy)-4-methoxyphenyl derivatives, structurally related to our hit GEBR...
The phosphodiesterase 4 (PDE4) enzyme, which is responsible for hydrolyzing cAMP in immune cells and...
In this study, a series of pyrazole derivatives containing 4-phenyl-2-oxazole moiety were designed a...
<p>cAMP, intracellular cyclic adenosine monophosphate, is a ubiquitous second messenger that plays a...
AbstractA series of novel hybrid molecules were designed rationally by connecting an indole moiety w...
Phosphodiesterase 4 catalyzes the hydrolysis of cyclic AMP and is a target for the development of an...
PDE4 inhibitors have been identified as therapeutic targets in a variety of conditions, particularly...
A new series of 3-(cyclopentyloxy)-4-methoxyphenyl derivatives, structurally related to our hit GEBR...
The phosphodiesterase 4 (PDE4) enzyme, which is responsible for hydrolyzing cAMP in immune cells and...
A quantitative structure-activity relationship (QSAR) study was performed to develop a model on a se...
Phosphodiesterase 4B (PDE4B) is a member of the phosphodiesterase family of proteins that plays a cr...
Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects i...
Phosphodiesterase type 4D (PDE4D) has been indicated as a promising target for treating neurodegener...
Subtype selectivity of phosphodiesterase 4 (PDE4) has been proposed to be the most salient feature f...